TARA

Protara Therapeutics, Inc. TARA

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $2.9M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$176.01M total
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/TARA

Earnings Per Share

13fpro.ai/company/TARA

Loading ratio trend…

About Protara Therapeutics, Inc. (TARA): stock profile, AI score and financials

Protara Therapeutics, Inc. (TARA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. TARA is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $2.9m in revenue and is scored on the micro-cap board instead. Top institutional holders of TARA by reported 13-F value include Jupiter Topco, BlackRock, MILLENNIUM MANAGEMENT, based on the most recent SEC filings. TARA trades on the Nasdaq exchange and files with the SEC under CIK 1359931. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TARA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Protara Therapeutics, Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1359931 →